Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

Prognostic Implication of Programmed Death-1-Positive Tumor-infiltrating Lymphocytes in Diffuse Large B-Cell Lymphoma

´ëÇѺ´¸®ÇÐȸÁö 2011³â 45±Ç 6È£ p.573 ~ 581
°í¿µ½Å, ¿À¿µÇÏ, ¹ÚÂù±Ý, ±è¿í¿¬, ÇÑÇý½Â, ÀÓ¼Ò´ö, Ȳż÷, ±è¿Ï¼·,
¼Ò¼Ó »ó¼¼Á¤º¸
°í¿µ½Å ( Ko Young-Sin ) 
Konkuk University College of Medicine Department of Pathology

¿À¿µÇÏ ( Oh Young-Ha ) 
Hanyang University Guri Hospital Department of Pathology
¹ÚÂù±Ý ( Park Chan-Kum ) 
Hanyang University College of Medicine Department of Pathology
±è¿í¿¬ ( Kim Wook-Youn ) 
Konkuk University College of Medicine Department of Pathology
ÇÑÇý½Â ( Han Hye-Seung ) 
Konkuk University College of Medicine Department of Pathology
ÀÓ¼Ò´ö ( Lim So-Dug ) 
Konkuk University College of Medicine Department of Pathology
Ȳż÷ ( Hwang Tae-Sook ) 
Konkuk University College of Medicine Department of Pathology
±è¿Ï¼· ( Kim Wan-Seop ) 
Konkuk University College of Medicine Department of Pathology

Abstract


Background : Programmed death-1 (PD-1) is physiologically expressed by germinal center-associated helper T-cells and has an inhibitory effect on T-cell activity.

Methods : We examined 63 cases of diffuse large B-cell lymphoma (DLBCL) and determined the number of PD-1-positive helper T-cells in a representative tumor area after immunohistochemical staining using a monoclonal antibody against PD-1. The PD-1-positive cells were counted in 3 high-power fields (HPFs; 400¡¿).

Results : Patients were divided into 2 groups: one with a high number of PD-1-positive cells (>20/HPF, n=33) and one with a low number of PD-1-positive cells (¡Â20/HPF, n=30). The former group showed decreased overall survival, but at a statistically non-significant level (p=0.073). A high number of PD-1-positive cells was more common in patients at an advanced clinical stage and with high international prognostic index score (p=0.025 and p=0.026, respectively). The number of extranodal sites also somewhat correlated with the PD-1 staining status (p=0.071). However, the number of PD-1-positive cells was not associated with patient age, serum lactate dehydrogenase level, and Eastern Cooperative Oncology Group performance score.

Conclusions : The high number of PD-1-positive cells might be associated with an unfavorable outcome in DLBCL patients.

Å°¿öµå

Lymphoma; large B-cell; diffuse; Programmed death-1 (PD-1); Lymphoma; Prognostic factor

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

  

µîÀçÀú³Î Á¤º¸

KCI
KoreaMed
KAMS